Immunocore Holdings annual depreciation and amortization
2021
2022
2023
2024
2025
Immunocore Holdings Depreciation & Amortization Growth & History (IMCR)
Immunocore Holdings's depreciation and amortization was $3.1M for fiscal 2025.
View full Immunocore Holdings company overviewImmunocore Holdings annual depreciation and amortization history
| Fiscal year | Period ended | Depreciation and amortization | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $3.1M | −$1.1M | −26.19% |
| 2024 | 2024-12-31 | $4.2M | $100,000 | +2.44% |
| 2023 | 2023-12-31 | $4.1M | −$1.2M | −22.64% |
| 2022 | 2022-12-31 | $5.3M | −$2.3M | −30.26% |
| 2021 | 2021-12-31 | $7.6M | — | — |
Immunocore Holdings quarterly depreciation and amortization
Q1.23
Q2.23
Q3.23
Q1.24
Q2.24
Q3.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Depreciation and amortization | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $1.0M | $246,000 | +31.54% |
| Q1 2026 | 2026-03-31 | $948,000 | $94,000 | +11.01% |
| Q4 2025 | 2025-12-31 | $834,000 | — | — |
| Q3 2025 | 2025-09-30 | $798,000 | −$237,000 | −22.90% |
| Q2 2025 | 2025-06-30 | $780,000 | −$212,000 | −21.37% |
| Q1 2025 | 2025-03-31 | $854,000 | −$157,000 | −15.53% |
| Q3 2024 | 2024-09-30 | $1.0M | −$42,000 | −3.90% |
| Q2 2024 | 2024-06-30 | $992,000 | −$37,000 | −3.60% |
| Q1 2024 | 2024-03-31 | $1.0M | $59,000 | +6.20% |
| Q3 2023 | 2023-09-30 | $1.1M | — | — |
| Q2 2023 | 2023-06-30 | $1.0M | — | — |
| Q1 2023 | 2023-03-31 | $952,000 | — | — |
Immunocore Holdings depreciation and amortization trends
Between the periods ended 2021-12-31 and 2025-12-31, Immunocore Holdings's depreciation and amortization decreased from $7.6M to $3.1M, a change of −$4.5M. The latest reported quarter, Q2 2026, shows $1.0M.
About the metric
What depreciation and amortization mean
Depreciation and amortization allocate the cost of tangible and intangible assets over their useful lives. These non-cash expenses reduce reported earnings and are commonly added back when calculating EBITDA and operating cash flow.
Calculation and source
Reported depreciation and amortization
TickerStat uses a combined depreciation and amortization value when reported. If a company reports the two components separately for an aligned period, they are added together without duplicating overlapping facts. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Immunocore Holdings source filings ↗